Bio-Rad Laboratories Inc (BIO)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $9.85B
Last updated: Nov 17, 2026 at 11:05 AM ET
Bio-Rad Laboratories Inc (BIO) P/E Ratio & Valuation History
Bio-Rad Laboratories (BIO) trades at 37.3x trailing earnings and 3.7x sales. Its P/E of 37.3x is above its 5-year median of 31.2x. Its forward P/E is 38.3x. The median P/E across 9 similar companies is 23.9x.
Current Multiples
Its forward P/E is above its trailing P/E, which implies earnings per share about 2.6% lower over the next year. Its free cash flow yield is 4.1%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 37.3x |
| Forward P/E | 38.3x |
| Price to sales | 3.7x |
| Price to book | 1.3x |
| EV/EBITDA | 22.2x |
| Price to FCF | 24.5x |
| EV/FCF | 26.4x |
| PEG | 1.2 |
| FCF yield | 4.1% |
Historical Medians
Against its 10-year medians, its P/E is 10.1% below 41.5x, its P/S is 5.1% below 3.9x and its P/B is 23.5% below 1.7x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 37.3x | 31.2x | 41.5x |
| P/S | 3.7x | 3.8x | 3.9x |
| P/B | 1.3x | 1.3x | 1.7x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 27.4x in 2023 to 191.9x in 2016.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $302.99 | 30.5x | 3.2x | 1.1x |
| 2024 | $328.51 | 31.9x | 3.6x | 1.4x |
| 2023 | $322.89 | 27.4x | 3.5x | 1.1x |
| 2022 | $420.49 | 29.5x | 4.5x | 1.3x |
| 2021 | $755.57 | 48.2x | 7.7x | 1.7x |
| 2020 | $582.94 | 55.4x | 6.8x | 1.8x |
| 2019 | $370.03 | 51.8x | 4.8x | 1.9x |
| 2018 | $232.22 | 40.9x | 3.0x | 1.7x |
| 2017 | $238.67 | 119.3x | 3.3x | 2.5x |
| 2016 | $182.28 | 191.9x | 2.6x | 2.1x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About BIO
What is BIO's forward P/E ratio?
Bio-Rad Laboratories has a forward P/E ratio of 38.3x.
Is BIO stock overvalued?
GNG's valuation label for BIO is Fairly valued. Its P/E of 37.3x compares with a median of 23.9x across 9 similar companies.
What is BIO's price to sales ratio?
Bio-Rad Laboratories has a price to sales ratio of 3.7x.
What is Bio-Rad Laboratories's average P/E ratio over 5 years?
Bio-Rad Laboratories's median P/E over the last 5 years is 31.2x, from 60 month-end values through Oct 2026.
What is BIO's PEG ratio?
Bio-Rad Laboratories has a PEG ratio of 1.2.
BIO pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors